Evidence map›Paper›PMID 35308518›Full record

ArticleFrontiers in medicine2022

Incidence Trends of Five Common Sexually Transmitted Infections Excluding HIV From 1990 to 2019 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2019.

Leiwen Fu, Yinghui Sun, Min Han, Bingyi Wang, Fei Xiao, Yiguo Zhou, Yanxiao Gao, Thomas Fitzpatrick, Tanwei Yuan, Peiyang Li and 9 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 4 pooled it
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 4 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Profile ofHuman vaccines & immunotherapeutics · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 3 countries.

Leiwen FuSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Yinghui SunSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Min HanDepartment of Medical Administration, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Bingyi WangSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Fei XiaoThe Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Yiguo ZhouSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Yanxiao GaoSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Thomas FitzpatrickDepartment of Internal Medicine, University of Washington, Seattle, WA, United States.
Tanwei YuanSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Peiyang LiSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Yuewei ZhanSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Yong LuSchool of Public Health, The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China.
Ganfeng LuoSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Junyi DuanClinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Zhongsi HongThe Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Christopher K FairleyCentral Clinical School, Monash University, Melbourne, VIC, Australia.
Tong ZhangClinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Jin ZhaoDepartment of HIV/AIDS Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
Huachun ZouSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Sun Yat-sen University · CNCapital Medical University · CNAlfred Health · AUFifth Affiliated Hospital of Sun Yat-sen University · CNGuangdong Provincial People's Hospital · CNGuiyang Medical University · CNShenzhen Center for Disease Control and Prevention · CNUniversity of Washington · US

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
NIAID NIH HHS T32 AI007140
6 · The paper itself

Abstract

Objective: Sexually transmitted infections (STIs) are common worldwide and pose a challenge to public health. We conducted this study to assess the annual incidence of five common STIs, including syphilis, chlamydia, gonorrhea, trichomoniasis, and genital herpes at the global, regional, and national levels. Materials and Methods: We obtained detailed data on STIs excluding HIV from 1990 to 2019 from the Global Burden of Disease (GBD) 2019 database. Estimated annual percentage change (EAPC) was calculated to quantify trends in age-standardized incidence rates (ASR) of STIs, stratified by gender, sociodemographic index (SDI) region, and pathogenic microorganism. Results: Globally, incident cases of STIs increased by 58.15% from 486.77 million in 1990 to 769.85 million in 2019, but the annual change in ASR was only -0.04% (95% CI -0.09 to 0.01) per year. EAPC was 0.16 (0.06 to 0.26) for syphilis, 0.09 (0.05 to 0.13) for genital herpes, 0.06 (0.03 to 0.09) for trichomoniasis, -0.21 (-0.36 to -0.06) for chlamydia, and -0.14 (-0.19 to -0.08) for gonorrhea. High SDI regions reported significant increases in ASR of syphilis and chlamydia. Conclusions: The burden of disease from STIs remains large, though control of STIs has contributed to the decreasing incidence in most regions, especially in the low-SDI regions. Globally, over the past 20 years, the ASR has remained stable for trichomoniasis and genital herpes decreased for chlamydia and gonorrhea, and increased for syphilis.

Indexed as

chlamydiagenital herpesglobal burdengonorrheaSTIssyphilistrichomoniasis

Identifiers

PMID35308518
PMCPMC8924524
OpenAlexW4214883834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.